We are live on ! Find out more
ARLZ

Aralez Pharmaceuticals Inc.
ARLZ

Delisted

ARLZ was delisted on the 20th of August, 2018.

Back to rankings

90 hedge funds and large institutions have $108M invested in Aralez Pharmaceuticals Inc. in 2016 Q1 according to their latest regulatory filings, with 90 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

27% less call options, than puts

Call options by funds: $1.22M | Put options by funds: $1.68M

Holders
90
Holders Change
+90
Holders Change %
–
% of All Funds
2.4%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
90
Increased
–
Reduced
–
Closed
–
Calls
$1.22M
Puts
$1.68M
Net Calls
-$456K
Net Calls Change
-$456K

Top Buyers

Rank Fund Capital Flow
1
PCM
PAR Capital Management
Massachusetts
+$27.7M
2
BC
Broadfin Capital
New York
+$19.6M
3
JAM
JW Asset Management
Florida
+$9.47M
4
DM
Deerfield Management
New York
+$8.48M
5
JHIU
Janus Henderson Investors US
Colorado
+$8.16M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
1
PAR Capital Management
Massachusetts
$19M +$27.7M +5,365,000 New
BC
2
Broadfin Capital
New York
$13.5M +$19.6M +3,800,000 New
JAM
3
JW Asset Management
Florida
$6.52M +$9.47M +1,836,375 New
DM
4
Deerfield Management
New York
$5.84M +$8.48M +1,644,583 New
JHIU
5
Janus Henderson Investors US
Colorado
$5.62M +$8.16M +1,583,134 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$5.42M +$7.87M +1,527,399 New
ECP
7
Elk Creek Partners
Colorado
$4.94M +$7.18M +1,392,746 New
BFA
8
BlackRock Fund Advisors
California
$4.88M +$7.08M +1,373,330 New
TLCM
9
Tiger Legatus Capital Management
New York
$4.53M +$6.57M +1,275,000 New
State Street
10
State Street
Massachusetts
$2.81M +$4.08M +790,730 New
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$2.26M +$3.28M +636,652 New
Renaissance Technologies
12
Renaissance Technologies
New York
$2.17M +$3.15M +610,819 New
Northern Trust
13
Northern Trust
Illinois
$1.94M +$2.81M +545,770 New
PI
14
Putnam Investments
Massachusetts
$1.68M +$2.44M +472,765 New
BIT
15
BlackRock Institutional Trust
California
$1.66M +$2.4M +466,564 New
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$1.63M +$2.37M +458,859 New
VOAM
17
Vertex One Asset Management
British Columbia, Canada
$1.5M +$2.18M +423,613 New
CIM
18
Contrarius Investment Management
Jersey
$1.46M +$2.11M +409,756 New
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$1.33M +$1.93M +375,327 New
CAD
20
Craig A. Drill
$1.21M +$1.75M +339,300 New
Deutsche Bank
21
Deutsche Bank
Germany
$1.16M +$1.69M +328,370 New
KAM
22
Kavi Asset Management
New York
$1.11M +$1.62M +313,627 New
TCIM
23
TIAA CREF Investment Management
New York
$1M +$1.46M +283,051 New
Fidelity Investments
24
Fidelity Investments
Massachusetts
$970K +$1.41M +273,270 New
TC
25
TFS Capital
Pennsylvania
$891K +$1.29M +250,969 New
1
2 3 4

ARLZ Hedge Fund Activity: Q1 2016 in Review

90 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Aralez Pharmaceuticals Inc. (ARLZ) for Q1 2016, worth a combined $108M.

Buyers outnumbered sellers: 90 funds opened new ARLZ positions and 0 closed out — a net gain of 90 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was PAR Capital Management, opening a new position worth an estimated $27.7M.

  • 90 institutional investors held Aralez Pharmaceuticals Inc. (ARLZ) as of Q1 2016, up from 0 in Q4 2015.
  • Funds reported $108M of Aralez Pharmaceuticals Inc. stock for Q1 2016.
  • 90 funds opened new Aralez Pharmaceuticals Inc. positions in Q1 2016 and 0 closed out, a net change of +90 holders.
  • The largest Aralez Pharmaceuticals Inc. buyer in Q1 2016 was PAR Capital Management, an estimated $27.7M added.

Based on aggregated 13F filings for Q1 2016.